Artelo Biosciences, Inc.(ARTL)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARTL Artelo Biosciences, Inc.

盘后交易 07-28 18:02:13 EDT

0.8801

-0.1299

-12.86%

盘后0.8700

-0.0101-1.15%

17:44 EDT

最高1.02	最低0.8800	成交量12.90万
今开1.00	昨收1.01	日振幅13.86%
总市值306.76万	流通市值196.52万	总股本348.55万
成交额12.18万	换手率5.78%	流通股本223.29万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARTL","market":"US","secType":"STK","nameCN":"Artelo Biosciences, Inc.","latestPrice":0.8801,"timestamp":1785268800000,"preClose":1.01,"halted":0,"volume":129035,"hourTrading":{"tag":"盘后","latestPrice":0.87,"preClose":0.8801,"latestTime":"17:44 EDT","volume":9238,"amount":7963.2423753,"timestamp":1785275089915,"change":-0.0101,"changeRate":-0.011476,"amplitude":0.138393},"delay":0,"changeRate":-0.12861386138613862,"floatShares":2232886,"shares":3485500,"eps":-28.022892,"marketStatus":"盘后交易","change":-0.1299,"latestTime":"07-28 18:02:13 EDT","open":1,"high":1.02,"low":0.88,"amount":121780.161967,"amplitude":0.138614,"askPrice":0.955,"askSize":2650,"bidPrice":0.85,"bidSize":6,"shortable":0,"etf":0,"ttmEps":-28.022892,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1785283200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":1.01,"preHourTrading":{"tag":"盘前","latestPrice":1.05,"preClose":1.01,"latestTime":"09:23 EDT","volume":1260,"amount":1248.704352,"timestamp":1785245019252,"change":0.04,"changeRate":0.039604,"amplitude":0.072772},"postHourTrading":{"tag":"盘后","latestPrice":0.87,"preClose":0.8801,"latestTime":"17:44 EDT","volume":9238,"amount":7963.2423753,"timestamp":1785275089915,"change":-0.0101,"changeRate":-0.011476,"amplitude":0.138393},"volumeRatio":1.175994},"requestUrl":"/m/hq/s/ARTL","defaultTab":"news","newsList":[{"id":"2654188880","title":"纳斯达克100指数势将进入回调阶段对AI投资最终回报的担忧正在削弱对推动今年股市上涨的科技巨头的市场情绪。周二纳斯达克1","url":"https://stock-news.laohu8.com/highlight/detail?id=2654188880","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2654188880?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:04","pubTimestamp":1785247494,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IWLG","NMAY","QCOC","QBIG","QXQ",".IXIC","QQQA","GROZ","QLD","QSIX","AIPO","QHDG","QQQG","ARTL","PQAP","QQQE","QSWN","FIVY","DQJN","QGRD","QQQW","QCLR","QCJA","ROCQ","PTNQ","QTOC","CPNJ","QYLE","QCJL","IQQ","BLGR","PSQ","QDTY","QRMI","QB","QQMG","QQQX","QDTE","NDX","QMAR","XMAG","QQQM","QQQT","CPNS","QTR","VTHR","YQQQ","QMMY","QID","QYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118062181","title":"Artelo Biosciences公布骨关节炎非临床研究结果，支持Art26.12成为慢性疼痛潜在首创新疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1118062181","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118062181?lang=zh_cn&edition=full","pubTime":"2026-07-16 20:55","pubTimestamp":1784206549,"startTime":"0","endTime":"0","summary":"Artelo Biosciences公布了一项非临床骨关节炎研究的结果，该研究支持其候选药物Art26.12成为治疗慢性疼痛的潜在首创新疗法。这项研究为Art26.12的开发提供了重要的临床前数据支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183709261","title":"Artelo 生物科学 - Art26.12 在非临床骨关节炎研究中显示疗效与萘普生相当","url":"https://stock-news.laohu8.com/highlight/detail?id=1183709261","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183709261?lang=zh_cn&edition=full","pubTime":"2026-07-16 20:48","pubTimestamp":1784206121,"startTime":"0","endTime":"0","summary":"Artelo Biosciences, Inc. 宣布，其候选药物 Art26.12 在一项非临床骨关节炎研究中，展现出了与常用镇痛抗炎药萘普生（Naproxen）相当的疗效。这一积极发现为该公司针对疼痛管理的新药研发管线注入了新的动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ARTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651938499","title":"纳斯达克金龙中国指数收涨2.92%，热门中概股普涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2651938499","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651938499?lang=zh_cn&edition=full","pubTime":"2026-07-16 05:12","pubTimestamp":1784149964,"startTime":"0","endTime":"0","summary":"当地时间7月15日，纳斯达克金龙中国指数收涨2.92%，热门中概股普涨，名创优品涨超9%，腾讯控股涨超5%，阿里巴巴、哔哩哔哩涨超4%，小鹏集团涨超3%，唯品会、爱奇艺、理想汽车、拼多多涨超2%，百度、网易涨超1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607163807921878.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607163807921878.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GPIQ","ARTL","KWEB","JEPQ","DRAG","QYLG","SQQQ","TQQY","YANG","PSQ","QQQ","ASHR","CNQQ","JCHI","TTTN","NVIW.SI","GROZ","PCCE","QQQA","CQQQ","FXI","LCLG","QID","ASHS","KCAI","TQQQ","CHAU","CWEB","FTEC","HXC","QQQJ","ONEQ","IWLG","MCH","TECS","QDTE","QQQE","YINN","FLCH","IYW","QQQM","MCHI","FIVY",".IXIC","NDX","159632","QLD","KALL","03086","NBCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152535810","title":"Artelo Biosciences中期数据：1300微克/日剂量下体重、瘦体重、活动能力改善且安全性良好","url":"https://stock-news.laohu8.com/highlight/detail?id=1152535810","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1152535810?lang=zh_cn&edition=full","pubTime":"2026-07-13 21:04","pubTimestamp":1783947885,"startTime":"0","endTime":"0","summary":"Artelo Biosciences公布的中期试验结果显示，在每日剂量高达1300微克的用药方案下，受试者的体重、瘦体重（肌肉量）以及活动能力均呈现出积极改善趋势，同时治疗耐受性良好，未出现重大安全性问题。这些数据为该公司相关候选药物的进一步开发提供了支持性证据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ARTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650185418","title":"募资265亿美元！SK海力士(SKHY.US)今晚登陆纳斯达克 能否摆脱“韩国折价”？","url":"https://stock-news.laohu8.com/highlight/detail?id=2650185418","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650185418?lang=zh_cn&edition=full","pubTime":"2026-07-10 16:54","pubTimestamp":1783673644,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，韩国芯片巨头SK海力士将于周五登陆纳斯达克，本次上市将检验该股能否摆脱长期存在的 “韩国折价” 困境。此次SK海力士通过发行美国存托凭证，将直接对接全球规模最庞大的资本市场，业内专家认为此举可能收窄 “韩国折价” 。LSEG数据显示，美光今年股价飙升近250%，SK海力士则上涨了240%。募资265亿美元，更大价值是接轨美资市场SK海力士本次ADR发行定价149美元，募资规模约265亿美元，有望刷新美股外资企业IPO纪录。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1465878.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IWLG","GROZ","QID","NJAN","ONEQ","QLD","EEMO","09086","07261","QQQJ","SKHYV","09834","IYW","FTEC",".IXIC","03086","07568","EDZ","QQQ","QQQX","NJUL","QDEC","PSQ","QQQY","02834","NDX","QYLG","TECS","SQQQ","LCLG","FIVY","JEPQ","03034","ARTL","NOCT","QDTE","QQQA","DRAL","07266","QQQE","GPIQ","NQmain","QQQM","RAM","MNQmain","SKHY","TQQQ","159632","NVIW.SI","TQQY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154960188","title":"Artelo Biosciences公布新数据，支持Art26.12成为治疗脊髓损伤相关慢性疼痛的潜在同类首创疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1154960188","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154960188?lang=zh_cn&edition=full","pubTime":"2026-07-01 20:47","pubTimestamp":1782910073,"startTime":"0","endTime":"0","summary":"Artelo Biosciences宣布了新的研究数据，这些数据有力支持其候选药物Art26.12有望成为治疗脊髓损伤所致慢性疼痛的潜在“同类首创”疗法。新公布的信息进一步验证了该药物的作用机制与临床前疗效，为其后续开发路径提供了关键支撑。慢性疼痛是脊髓损伤后常见的严重并发症，目前治疗选择有限且常伴随显著副作用，因此存在巨大的未满足医疗需求。Art26.12以其新颖的作用靶点，旨在从根源上调控疼痛信号通路，可能为患者带来全新的治疗希望。公司表示，这些积极数据将指导下一阶段的临床开发计划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647757553","title":"霍尼韦尔宇航完成从霍尼韦尔科技分拆，正式在纳斯达克挂牌交易。","url":"https://stock-news.laohu8.com/highlight/detail?id=2647757553","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647757553?lang=zh_cn&edition=full","pubTime":"2026-06-29 19:07","pubTimestamp":1782731256,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4534","LU0683600562.USD","IE00B1BXHZ80.USD","BK4585","BK4602","LU0787776722.HKD","LU0868494617.USD","ARTL","IE0034235188.USD","BK4588","LU0868494708.USD","LU0942090050.USD","BK4550","BK4007","BK4206","HON"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646035678","title":"纳斯达克 100 指数期货在美国经济数据公布后涨至盘中高位","url":"https://stock-news.laohu8.com/highlight/detail?id=2646035678","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646035678?lang=zh_cn&edition=full","pubTime":"2026-06-25 20:34","pubTimestamp":1782390881,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据 Gate 行情数据显示，纳斯达克 100 指数期货在美国经济数据公布后涨至盘中高位。 ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2273624","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOLY","MINT","BOND","QQQY","TQQQ","ITB","PBDC","GOVT","DRV","NVIW.SI","USHY","DRN","VDC","GBIL","ARTL","DBND","ONEQ","VGLT","JEPQ","TYO","TBIL","IYR","TBT","XLRE","VCIT","IEI","XLP","IYW","NDX","159632","FGBXmain","UBT","VCSH","EDV","QQQ","03086","XRT","ZROZ","BSV",".IXIC","QQQA","NQmain","SCHH","QDTE","XHB","DBA","SCHO","NAIL","MNQmain","QLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646264828","title":"美银警告：半导体驱动下，纳斯达克已达\"泡沫临界点\"","url":"https://stock-news.laohu8.com/highlight/detail?id=2646264828","media":"华尔街见闻","labels":["economic"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646264828?lang=zh_cn&edition=full","pubTime":"2026-06-25 11:59","pubTimestamp":1782359953,"startTime":"0","endTime":"0","summary":"美国银行衍生品团队发出警告，纳斯达克100自3月底累计涨幅约32%，估值压力持续积聚，纳斯达克泡沫风险指标（BRI）已升至0.8关键阈值。美银指出，市场在宏观逆风下的超强韧性，恰是泡沫积聚的典型特征。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3775478","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QQQJ","QDTE","CHPS",".IXIC","ARTL","159582","SOXS","CHPY","QQQY","TQQQ","07266","07261","SOXX","SOXL","QYLG","NDX","NOCT","USD","JEPQ","02834","TQQY","VGT","XSD","SOXQ","SMH","SOXY","ONEQ","QLD","SQQQ","07568","TECS","GPIQ","PSQ","SSG","TEKX","QQQE","SMHX","PSI","QQQA","159632","NQmain","IYW","FTXL","QQQM","MNQmain","NVIW.SI","QQQ","QID","03086","FTEC"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2643220449","title":"高尔夫击球追踪平台Game Your Game(GYGY.US)拟在纳斯达克直接上市 过去12个月账面收入为6万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2643220449","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643220449?lang=zh_cn&edition=full","pubTime":"2026-06-15 14:35","pubTimestamp":1781505300,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，开发人工智能高尔夫击球追踪及表现分析工具的 Game Your Game 向美国证券交易委员会提交注册申请，拟在纳斯达克完成直接上市。此次上市将由现有股东出售流通普通股，Game Your Game 将不会通过此次上市募集新资金。以此价格计算，Game Your Game 的市场价值将达到 1.29 亿美元。该公司成立于 2016 年，在截至 2026 年 3 月 31 日的 12 个月内，其账面收入为 6 万美元。Game Your Game 此前已于 2026 年 2 月 17 日就该交易秘密提交了上市申请。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1454299.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["QQQM","159632","ARTL","IYW","03086","QMAR","QQQE","JEPQ","NQmain","NOCT","FTEC","QID","TQQY","QDTE","SQQQ","PSQ","07522","BK1147","NJAN","NDX","07568","BK4007","QQQY","QQQA","QYLG","NVIW.SI","QLD","MNQmain","NAPR","QQQJ","ONEQ","07261","TQQQ","QDEC","03034","02834","NJUL","09086","IPOS","03455","09834","QQQ",".IXIC","07266","TECS","GPIQ","QQQX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2642296105","title":"人类史上最大规模IPO上市，SpaceX首日开盘价预示为每股174美元，较发行价高开29%，马斯克并未出现在纳斯达克敲钟仪式上","url":"https://stock-news.laohu8.com/highlight/detail?id=2642296105","media":"金融界","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642296105?lang=zh_cn&edition=full","pubTime":"2026-06-12 22:00","pubTimestamp":1781272853,"startTime":"0","endTime":"0","summary":"6月12日，SPACEX股票预示首日开盘价为每股174美元，将比IPO发行价高出29%。SPACEX IPO据悉吸引了超过2500亿美元的机构认购。SPACEX据悉将20%份额分配给散户投资者。本次发售约5.56亿股ClassA普通股，每股定价135美元，基础募资规模高达750亿美元。按6月11日公布的IPO价格计算，马斯克持有的SpaceX股份价值约8670亿美元。招股书显示，SpaceX在2026年第一季度营收47亿美元，同期净亏损42亿美元。在SpaceX三项主营业务中，星链成为唯一盈利的业务，为火箭发射和AI部门“输血”。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2026/06/12220057452711.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["TSLQ","TSLZ","TQQY","NDX","TSLA","TSYY","TSDD","ARTL","SPCH","XOVR","DXYZ",".IXIC","QQQ","TECS","SNK","SPCU","QQQE","NVIW.SI","TQQQ","UUP","QID","03086","SPAL","FTEC","TSLG","TSLL","TSLO","IYW","JEPQ","159632","TSLR","PSQ","TSLS","NQmain","QDTE","QQQJ","UDN","SQQQ","SPCX","TESL","QQQM","SPCF","QYLG","TSII","UFO","QLD","TEST","ONEQ","IPOS"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2640153656","title":"癌症肽疗法新星冲刺纳斯达克！Parabilis(PBLS.US)拟募资4.5亿美元 以26亿美元市值登陆美股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640153656","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640153656?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:39","pubTimestamp":1780562365,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，聚焦癌症治疗的美国生物科技公司Parabilis Medicines在美东时间6月3日确定4.5亿美元IPO条款。按拟议区间的中点计算，Parabilis Medicines 的市值将达到 26亿美元。Parabilis Medicines 是一家处于临床阶段的生物科技公司，开发靶向此前被认为“不可成药”的蛋白质的药物。Parabilis此前已经获得华尔街金融巨头Fidelity和RA Capital支持，已通过私募融资筹集近10亿美元，最近一次是在1月的F轮融资中筹集超过3亿美元。Parabilis Medicines成立于2015年。该公司计划在纳斯达克以代码“PBLS”上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450121.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02834","QDTE","QDEC","MNQmain","QQQA","QQQM","07266","GPIQ","09834","07568","QQQJ","NOCT","JEPQ","ONEQ","03086","SQQQ","159632","PSQ","NQmain","QMAR","QLD","ARTL","IYW","QYLG","TECS","03455","BK1147","NJUL","NVIW.SI","QQQE","QQQY","QID","TQQY","03034",".IXIC","FTEC","09086","NAPR","TQQQ","NJAN","QQQ","NDX","QQQX","07522","07261","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640941798","title":"热门中概股走高，纳斯达克金龙中国指数涨幅扩大至逾2.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640941798","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640941798?lang=zh_cn&edition=full","pubTime":"2026-06-02 23:07","pubTimestamp":1780412860,"startTime":"0","endTime":"0","summary":"热门中概股走高，纳斯达克金龙中国指数涨幅扩大至逾2.5%，阿里巴巴、理想汽车涨近6%，京东、百度涨超5%，小鹏集团涨近5%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606023757901373.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606023757901373.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["TTTN","CNQQ","03034","KWEB","QQQE","09086","QQQ","CHAU","03086","TQQQ","XPP","QDEC","SQQQ","CWEB","IYW","YINN","HXC","QID","FXI",".IXIC","QDTE","FXP","NVIW.SI","QQQJ","QQQM","PSQ","QQQY","GPIQ","MCHI","TECS","ASHR","NQmain","JEPQ","07261","QYLG","MNQmain","ASHS","CQQQ","QQQA","NOCT","YANG","FTEC","TQQY","ARTL","159632","QLD","NAPR","ONEQ","NDX","DRAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638508896","title":"江苏模具制造商宁泰模具(NTMJ.US)递表纳斯达克：IPO定价4至5美元 拟募资2800万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2638508896","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638508896?lang=zh_cn&edition=full","pubTime":"2026-05-27 16:30","pubTimestamp":1779870634,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国定制模具及注塑产品制造商宁泰模具周二向美国证券交易委员会提交文件，计划通过首次公开募股筹集2800万美元。该公司计划发行630万股股票，发行价区间为每股4至5美元。按发行价区间中值计算，宁泰模具的市值将达到1.23亿美元。这家总部位于江苏泰州的公司成立于2012年，截至2025年12月31日的12个月内，其营收为1900万美元。宁泰模具于2025年11月12日秘密提交了IPO申请。Kingswood Capital Markets是此次IPO的唯一承销商。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446565.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["QQQM","159632","ARTL","IYW","03086","QMAR","QQQE","JEPQ","NQmain","NOCT","FTEC","QID","TQQY","QDTE","SQQQ","PSQ","07522","BK1147","NJAN","UDN","NDX","07568","BK4007","QQQY","QQQA","QYLG","NVIW.SI","QLD","MNQmain","UUP","NAPR","QQQJ","ONEQ","07261","TQQQ","QDEC","03034","02834","NJUL","09086","IPOS","03455","09834","QQQ",".IXIC","07266","TECS","GPIQ","QQQX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147809387","title":"Artelo Biosciences, Inc. 宣布将于2026年5月18日终止市场发行协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1147809387","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147809387?lang=zh_cn&edition=full","pubTime":"2026-05-16 04:04","pubTimestamp":1778875455,"startTime":"0","endTime":"0","summary":"根据向美国证券交易委员会提交的文件，Artelo Biosciences, Inc. 已决定终止其市场发行协议。该终止决定将于2026年5月18日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ARTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194739422","title":"Artelo Biosciences发布业务进展，概述未来里程碑并公布2026年第一季度财务业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1194739422","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194739422?lang=zh_cn&edition=full","pubTime":"2026-05-15 04:09","pubTimestamp":1778789365,"startTime":"0","endTime":"0","summary":"Artelo Biosciences 近日发布了最新的业务进展，详细阐述了公司即将迎来的关键里程碑，并同时公布了其2026年第一季度的财务业绩。\n此次更新涵盖了公司研发管线的重要节点，为投资者勾勒出未来的发展路径。在财务方面，公司也披露了截至2026年第一季度的运营与财务数据。\n通过整合业务动态与财务结果，Artelo Biosciences旨在向市场提供关于其战略执行与财务状况的全面视角。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ARTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634869497","title":"科兴生物发布2025年半年报，纳斯达克摘牌风险暂解","url":"https://stock-news.laohu8.com/highlight/detail?id=2634869497","media":"新京报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634869497?lang=zh_cn&edition=full","pubTime":"2026-05-09 15:36","pubTimestamp":1778312208,"startTime":"0","endTime":"0","summary":"5月8日晚间，科兴生物（纳斯达克股票代码：SVA）披露2025年半年度财报（未经审计），报告期内，公司销售收入1.3亿美元，同比微增1.24%；归属于普通股股东的净亏损为2170万美元。研发投入1.27亿美元，占同期营收比激增至97.4%。截至目前，科兴生物已完成纳斯达克要求的截至2024年年报及2025年半年报的报送，摘牌风险暂时解除。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605093732214995.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605093732214995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["NQmain","PSQ","QLD","TECS",".IXIC","QDTE","TQQQ","BK1147","NVIW.SI","SQQQ","IYW","ONEQ","FTEC","ARTL","QQQY","BK4007","TQQY","SVA","NDX","QYLG","BK4139","QQQA","MNQmain","JEPQ","QQQJ","QQQ","QQQM","159632","QQQE","GPIQ","03086","QID"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142393283","title":"Artelo Biosciences与Sciencemachine达成战略合作 共同开发FABP5抑制剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1142393283","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142393283?lang=zh_cn&edition=full","pubTime":"2026-04-28 20:27","pubTimestamp":1777379235,"startTime":"0","endTime":"0","summary":"Artelo Biosciences, Inc.宣布与Sciencemachine建立战略合作伙伴关系，双方将重点推进脂肪酸结合蛋白5（FABP5）抑制剂的研发进程。此次合作旨在整合两家公司在生物医药领域的专业优势，加速创新疗法的开发。\n通过资源共享与技术互补，Artelo Biosciences将与Sciencemachine共同探索FABP5抑制剂在肿瘤治疗等领域的应用潜力。该合作标志着Artelo Biosciences在扩大研发管线方面迈出重要一步，也为双方未来在生物制药领域的深度协作奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ARTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628478307","title":"阿拉玛生物科学纳斯达克上市首日股价大涨，估值达15亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2628478307","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628478307?lang=zh_cn&edition=full","pubTime":"2026-04-18 01:00","pubTimestamp":1776445254,"startTime":"0","endTime":"0","summary":"阿拉玛生物科学（Alamar Biosciences）周五在纳斯达克首次公开募股，股价大涨 33%，这家蛋白质生物标志物检测平台公司估值达到 15.3 亿美元。\n　　这家总部位于加州弗里蒙特的企业开盘价为每股 22.60 美元，其发行价为 17 美元。\n　　阿拉玛此次增发规模上调，以 15 至 17 美元发行区间的上限定价，发行约 1130 万股，募资 1.913 亿美元。\n　　该公司成立于 2018 年，专注研发可检测血液中低浓度蛋白质生物标志物的设备，用于疾病研究与诊断。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-18/doc-inhuvvnw0766523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["QQQY","QLD","BK4007","NBI","QQQ","NQmain","QID","TQQQ","PSQ","GPIQ","QQQE","NVIW.SI","QQQM","IYW","FTEC","SQQQ","TQQY","QQQJ","QYLG","JEPQ","ARTL","QQQA","MNQmain","QDTE","ONEQ"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.artelobio.com","stockEarnings":[{"period":"1week","weight":-0.0982},{"period":"1month","weight":-0.0982},{"period":"3month","weight":-0.7171},{"period":"6month","weight":-0.814},{"period":"1year","weight":-0.9755},{"period":"ytd","weight":-0.724}],"compareEarnings":[{"period":"1week","weight":-0.004},{"period":"1month","weight":0.0139},{"period":"3month","weight":0.0385},{"period":"6month","weight":0.0628},{"period":"1year","weight":0.1601},{"period":"ytd","weight":0.0838}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Artelo Biosciences, Inc.于2011年5月2日在内华达州注册成立。该公司是一家临床生物制药公司，致力于开发和商业化旨在调节内源性信号通路的治疗方法，包括内源性大麻素系统（“ ECS”），形成整个身体生化通信网络的一系列受体和神经递质。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.048793},{"month":2,"riseRate":0.375,"avgChangeRate":0.02148},{"month":3,"riseRate":0.25,"avgChangeRate":0.078441},{"month":4,"riseRate":0.25,"avgChangeRate":-0.122994},{"month":5,"riseRate":0.375,"avgChangeRate":-0.068022},{"month":6,"riseRate":0.25,"avgChangeRate":0.069717},{"month":7,"riseRate":0.25,"avgChangeRate":-0.081007},{"month":8,"riseRate":0,"avgChangeRate":-0.147393},{"month":9,"riseRate":0.375,"avgChangeRate":-0.102653},{"month":10,"riseRate":0.125,"avgChangeRate":-0.187173},{"month":11,"riseRate":0.375,"avgChangeRate":-0.029503},{"month":12,"riseRate":0.75,"avgChangeRate":0.010567}],"exchange":"NASDAQ","name":"Artelo Biosciences, Inc.","nameEN":"Artelo Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Artelo Biosciences, Inc.(ARTL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Artelo Biosciences, Inc.(ARTL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Artelo Biosciences, Inc.,ARTL,Artelo Biosciences, Inc.股票,Artelo Biosciences, Inc.股票老虎,Artelo Biosciences, Inc.股票老虎国际,Artelo Biosciences, Inc.行情,Artelo Biosciences, Inc.股票行情,Artelo Biosciences, Inc.股价,Artelo Biosciences, Inc.股市,Artelo Biosciences, Inc.股票价格,Artelo Biosciences, Inc.股票交易,Artelo Biosciences, Inc.股票购买,Artelo Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Artelo Biosciences, Inc.(ARTL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Artelo Biosciences, Inc.(ARTL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}